Skip to content

Summary of Infants Weighing 500 Grams or Less

Microcephaly At Birth As a Potential Predictor of Poor Prognosis in Infants Weighing 500 Grams or Less: a Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05322980
Enrollment
22
Registered
2022-04-12
Start date
2022-04-05
Completion date
2022-12-31
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Extremely Low Birth Weight, Microcephaly

Keywords

500 grams or less, prognosis

Brief summary

This is a retrospective single-center cohort study. The comparison in short- and long-term outcomes will be made between those with and without primary microcephaly in infants weighing ≤ 500 g.

Detailed description

This is a retrospective single-center cohort study. The study setting is a level IV neonatal intensive care unit (NICU) at Nagano Children's Hospital in Nagano, Japan. We will retrospectively collect the data of those who were admitted to Nagano Children's Hospital NICU between January 1, 2015, and December 31, 2019. Eligible infants will be identified using our neonatal database and clinical records. The extracted data includes maternal background information and clinical course, infant's status at birth, the clinical course in NICU, and the follow-up data at 6 and 18 months of corrected age. Among the eligible infants, those with a z score of birth head circumference \< -2 will be classified into the Microcephaly group and others into the Control group. The z score is calculated using the Japanese growth standard.

Interventions

DIAGNOSTIC_TESTMicrocephaly

Those with a z score of birth head circumference \< -2 (primary microcephaly) are classified into the Microcephaly group.

Sponsors

Nagano Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Live-born infants weighing ≤ 500 g at birth * Infants whose clinical course is available in the electronic medical record

Exclusion criteria

* Stillbirths * Infants who received only palliative care at birth * Outborn infants * Infants whose assessment at 3 years of age not completed at data analysis

Design outcomes

Primary

MeasureTime frameDescription
Rate of neurodevelopmental impairment3 years of ageHaving at least one of the following conditions: cognitive impairment, cerebral palsy, visual impairment, or hearing impairment. Cognitive impairment was defined as a modified DQ score of ≤ 70 using the Kyoto Scale of Psychological Development. CP was defined as (1) a non-progressive disorder of the central nervous system appearing in the early years of life and clinically characterized by a persistent but not unchanging impairment of movement and posture and/or (2) the Gross Motor Function Classification System level ≥ II. Visual impairment was defined as unilateral or bilateral blindness, or any other condition requiring corrective lenses, which were diagnosed or determined by ophthalmologists. Hearing impairment was defined as unilateral or bilateral hearing loss that requires a hearing aid. The diagnosis of hearing loss was made by otolaryngologists using auditory steady-state response.

Secondary

MeasureTime frameDescription
Rate of severe bronchopulmonary dysplasiaAt 36 weeks' postmenstrual ageThe definition of bronchopulmonary dysplasia proposed by the National Institute of Child Health and Human Development is used to classify the severity of bronchopulmonary dysplasia. Those who need ≥ 30% of oxygen or any mechanical respiratory support at 36 weeks of gestation are classified as having severe bronchopulmonary dysplasia.
Rate of need for surgery for patent ductus arteriosusIn neonatal intensive care unit, an average of up to 4 weeks of lifePatent ductus arteriosus is diagnosed by neonatologists using echocardiography and clinical signs.
Rate of severe intraventricular hemorrhageIn neonatal intensive care unit, an average of up to 2 weeks of lifeIntraventricular hemorrhage is diagnosed by neonatologists using head ultrasound. Severe IVH was defined as grade III or IV by the classification of Papile.
Rate of periventricular leukomalaciaIn neonatal intensive care unit, an average of up to 40 weeks' postmenstrual agePeriventricular leukomalacia is diagnosed using head ultrasound or magnetic resonance imaging, typically cysts formation in the periventricular white matter.
Rate of necrotizing enterocolitisIn neonatal intensive care unit, an average of up to 2 weeks of lifeThe diagnosis with necrotizing enterocolitis.
Rate of sepsisIn neonatal intensive care unit, an average of up to 4 weeks of lifeSepsis is defined as septicemia or bacteremia with a positive culture result of the blood and/or cerebrospinal fluid.
Rate of need for treatment for retinopathy of prematurityIn neonatal intensive care unit, an average of up to 40 weeks' postmenstrual ageThe diagnosis of retinopathy of prematurity and the decision on the need for treatment were made by ophthalmologic examination.
WeightAt 40 weeks' postmenstrual age or at discharge (approximately 40 weeks' postmenstrual age)Physical measurement.
LengthAt 40 weeks' postmenstrual age or at discharge (approximately 40 weeks' postmenstrual age)Physical measurement.
Head circumferenceAt 40 weeks' postmenstrual age or at discharge (approximately 40 weeks' postmenstrual age)Physical measurement.
Postmenstrual ageAt discharge, an average at 40 weeks' postmenstrual agePostmenstrual age is calculated based on their gestational age and date at birth.
Survival rateAt discharge from neonatal intensive care unit, an average at 40 weeks' postmenstrual age.Survival rate is the proportion of those have survived.
TracheostomyIn neonatal intensive care unit, an average at 40 weeks' postmenstrual ageNeed for tracheostomy.
Length of hospital stayIn neonatal intensive care unit, an average at 40 weeks' postmenstrual ageThe initial hospitalization.
Modified developmental quotientAt 3 years of ageModified developmental quotient is calculated by dividing developmental age (measured by the Kyoto Scale of Psychological Development) by the corrected age.
Rate of cerebral palsyAt 3 years of ageCerebral palsy is defined as (1) a non-progressive disorder of the central nervous system appearing in early years of life and clinically characterized by a persistent but not unchanging impairment of movement and posture and/or (2) the Gross Motor Function Classification System level ≥ II.
Rate of visual impairmentAt 3 years of ageVisual impairment is defined as unilateral or bilateral blindness, or any other condition requiring corrective lenses, which were diagnosed or determined by ophthalmologists.
Rate of hearing impairmentAt 3 years of ageHearing impairment is defined as unilateral or bilateral hearing loss that requires a hearing aid. The diagnosis of hearing loss was made by otolaryngologists using auditory steady-state response.
Rate of those who need home oxygen therapyAt 3 years of ageNeed for home oxygen therapy.
Rate of those who need tracheostomyAt 3 years of ageNeed for tracheostomy.
Rate of those who need tube feeding or gastrostomyAt 3 years of ageNeed for tube feeding or gastrostomy.
Rate of those who need rehospitalizationAfter 18 months of corrected age unit until 3 years of ageNeed for rehospitalization.
HeightAt 3 years of agePhysical measurement.
Need for home oxygen therapyAt discharge, an average at 40 weeks' postmenstrual ageNeed for home oxygen therapy.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026